Latest filings (excl ownership)
10-Q
2024 Q1
Quarterly report
1 May 24
8-K
IDEXX Laboratories Announces First Quarter Results
1 May 24
ARS
2023 FY
Annual report to shareholders
27 Mar 24
DEFA14A
Additional proxy soliciting materials
27 Mar 24
DEF 14A
Definitive proxy
27 Mar 24
10-K
2023 FY
Annual report
22 Feb 24
8-K
Results of Operations and Financial Condition
5 Feb 24
8-K
Departure of Directors or Certain Officers
7 Dec 23
10-Q
2023 Q3
Quarterly report
1 Nov 23
8-K
Results of Operations and Financial Condition
1 Nov 23
10-Q
2023 Q2
Quarterly report
1 Aug 23
8-K
Results of Operations and Financial Condition
1 Aug 23
8-K
IDEXX Laboratories Elects Irene Chang Britt to Board of Directors
12 Jul 23
SD
Conflict minerals disclosure
31 May 23
8-K
Submission of Matters to a Vote of Security Holders
19 May 23
10-Q
2023 Q1
Quarterly report
2 May 23
8-K
Results of Operations and Financial Condition
2 May 23
ARS
2022 FY
Annual report to shareholders
31 Mar 23
DEFA14A
Additional proxy soliciting materials
31 Mar 23
DEF 14A
Definitive proxy
31 Mar 23
10-K
2022 FY
Annual report
16 Feb 23
8-K
IDEXX Laboratories Announces Fourth Quarter and Full Year 2022 Results
6 Feb 23
10-Q
2022 Q3
Quarterly report
1 Nov 22
8-K
IDEXX Laboratories Announces Third Quarter Results
1 Nov 22
8-K
Entry into a Material Definitive Agreement
21 Oct 22
10-Q
2022 Q2
Quarterly report
2 Aug 22
8-K
IDEXX Laboratories Announces Second Quarter Results
2 Aug 22
8-K
Amendments to Articles of Incorporation or Bylaws
15 Jul 22
8-K
Regulation FD Disclosure
14 Jun 22
SD
Conflict minerals disclosure
31 May 22
8-K
Submission of Matters to a Vote of Security Holders
13 May 22
10-Q
2022 Q1
Quarterly report
4 May 22
8-K
IDEXX Laboratories Announces First Quarter Results
4 May 22
DEFA14A
Additional proxy soliciting materials
31 Mar 22
DEF 14A
Definitive proxy
31 Mar 22
10-K
2021 FY
Annual report
16 Feb 22
8-K
IDEXX Laboratories Announces Fourth Quarter and Full Year 2021 Results
2 Feb 22
8-K
Entry into a Material Definitive Agreement
9 Dec 21
10-Q
2021 Q3
Quarterly report
2 Nov 21
8-K
IDEXX Laboratories Announces Third Quarter Results
2 Nov 21
Latest ownership filings
4
JAMES F POLEWACZYK
7 Mar 24
4
Sophie V. Vandebroek
7 Mar 24
144
Notice of proposed sale of securities
6 Mar 24
144
Notice of proposed sale of securities
5 Mar 24
4
JONATHAN JAY MAZELSKY
4 Mar 24
4
JONATHAN JAY MAZELSKY
22 Feb 24
4
Sharon E. Underberg
20 Feb 24
4
BRIAN P MCKEON
20 Feb 24
4
Sharon E. Underberg
16 Feb 24
4
Martin Alexander Smith
16 Feb 24
4
Michael Schreck
16 Feb 24
4
JAMES F POLEWACZYK
16 Feb 24
4
BRIAN P MCKEON
16 Feb 24
4
JONATHAN JAY MAZELSKY
16 Feb 24
4
Michael Lane
16 Feb 24
4
Michael Perkins Johnson
16 Feb 24
4
Nimrata Hunt
16 Feb 24
4
GEORGE FENNELL
16 Feb 24
4
Michael G Erickson
16 Feb 24
SC 13G/A
VANGUARD GROUP INC
13 Feb 24
4
JONATHAN W AYERS
12 Feb 24
4
GEORGE FENNELL
9 Feb 24
4
JONATHAN W AYERS
9 Feb 24
4
BRIAN P MCKEON
9 Feb 24
4
JONATHAN JAY MAZELSKY
9 Feb 24
144
Notice of proposed sale of securities
8 Feb 24
144
Notice of proposed sale of securities
7 Feb 24
144
Notice of proposed sale of securities
7 Feb 24
4
DANIEL M JUNIUS
1 Feb 24
SC 13G/A
BlackRock Inc.
24 Jan 24
3
Michael Schreck
5 Jan 24
3
GEORGE FENNELL
5 Jan 24
3
Michael G Erickson
5 Jan 24
4
JAMES F POLEWACZYK
8 Dec 23
SC 13G/A
VANGUARD GROUP INC
8 Dec 23
144
Notice of proposed sale of securities
7 Dec 23
4
JONATHAN JAY MAZELSKY
6 Dec 23
4
JONATHAN W AYERS
6 Dec 23
144
Notice of proposed sale of securities
4 Dec 23
4
JONATHAN W AYERS
1 Dec 23